文献速递头颈外科

siRNA敲低XPO5对头颈癌细胞生物学行为的影响

Effects of Knockdown of XPO5 by siRNA on the Biological Behavior of Head and Neck Cancer Cells.
PubMed 文献 · Laryngoscope · 2021-07-30

该体外翻译研究在SCC-9、FaDu SCC-90和Detroit-562细胞系中评估XPO5表达,并用XPO5-siRNA沉默其表达后检测细胞增殖、迁移和凋亡。结果显示转移性细胞中XPO5在mRNA、蛋白和细胞内水平均上调,沉默XPO5可降低增殖、延缓伤口愈合、增加Caspase-3活性,提示XPO5在HNSCC中具致癌作用,可能作为生物标志物和治疗靶点。

要点

  • 转移性HNSCC细胞中XPO5在mRNA、蛋白及细胞内水平均上调。
  • XPO5-siRNA沉默XPO5可降低HNSCC细胞增殖并延缓伤口愈合。
  • 沉默XPO5增加HNSCC细胞Caspase-3酶活性。

核心结论

  • 体外实验首次描述XPO5在HNSCC生物学中的致癌作用。
  • XPO5可能作为HNSCC诊断-治疗-随访中的潜在生物标志物和治疗靶点。

研究设计与样本

  • 体外翻译研究,采用SCC-9、FaDu SCC-90和Detroit-562细胞系。
  • 用定量逆转录聚合酶链反应、Western-blot和免疫荧光分别评估XPO5的mRNA、蛋白和细胞内表达。
  • 用XPO5-siRNA在体外模型中沉默基因表达以分析功能作用。

主要发现

  • 与原发性细胞相比,转移性HNSCC细胞中XPO5在mRNA、蛋白和细胞内水平均上调。
  • XPO5-siRNA转染成功敲低XPO5,mRNA、蛋白和细胞内水平均受抑制。
  • 沉默XPO5导致HNSCC细胞系增殖减少、伤口愈合延迟、Caspase-3酶活性增加(与对照相比)。

临床怎么用

  • XPO5可作为HNSCC潜在的生物标志物和治疗靶点,用于诊断-治疗-随访。

局限性

  • 证据等级为NA,研究为体外实验,结论需进一步体内和临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: Dysregulated expression of microRNAs (miRNAs) and dysregulation of the mechanisms that regulate them are associated with carcinogenesis. Exportin-5 (XPO5), a member of the Karyopherin family, is responsible for the transfer of pre-miRNAs from the nucleus to the cytoplasm. Despite the high oncogenic potential of XPO5 as a critical regulator of the biogenesis of miRNAs, its role in head and neck squamous cell carcinoma (HNSCC) biology has not been explained yet. STUDY DESIGN: In-vitro translational. METHODS: The expression of XPO5 at the mRNA, protein, and intracellular level in SCC-9, FaDu SCC-90, and Detroit-562 cell lines were evaluated with quantitative reverse transcription polymerase chain reaction, Western-blot analysis, and immunofluorescence staining, respectively. The functional role of XPO5 in HNSCC was analyzed by silencing the gene expression with XPO5-small interfering RNA (siRNA) in the in vitro model. Cell proliferation, migration capacity, and apoptosis in XPO5 knockdown HNSCC cell lines were evaluated by MTT, wound-healing, and caspase-3 assay, respectively. RESULTS: Expression of XPO5 was determined to be upregulated at mRNA, protein, and intracellular level in metastatic cells compared to primary cells in HNSCC. XPO5 gene expression was knockdown by XPO5-siRNA transfection, verifying that it was suppressed at the mRNA, protein, and intracellular level. Silencing XPO5 caused a decrease in cell proliferation, delay in wound healing, and increase in Caspase-3 enzyme activity in HNSCC cell lines compared to control. CONCLUSIONS: This report is the first to describe the oncogenic role of XPO5 in HNSCC biology by in vitro experiments. Consequently, XPO5 can be used as a potential biomarker and therapeutic target molecule against the disease in the diagnosis-treatment-follow-up of HNSCC. LEVEL OF EVIDENCE: NA Laryngoscope, 132:569-577, 2022.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Özdaş S, Canatar İ, Özdaş T, et al. Effects of Knockdown of XPO5 by siRNA on the Biological Behavior of Head and Neck Cancer Cells. Laryngoscope. 2021. PMID: 34328643. doi:10.1002/lary.29787

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。